|
|
 |
|
Viewing report
|
|
|
|
Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles
GBI Research, Sep 2011, Pages: 87
This report provides in-depth analysis of drivers and barriers that impact the global critical care market. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. The report analyzes the markets for factor XIII concentrates, fibrinogen concentrates, albumins, antithrombins and prothrombin complex concentrates in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. This includes treatment usage patterns, average annual cost of therapy and market size forecast until 2017 for the key geographies as well as the leading therapeutic segments. The report also provides information on the R&D product pipeline and explores the competitive landscape, including major players in the critical care market. Finally, the report includes analysis on mergers and acquisitions (M&As) in the critical care market.
The Global Critical Care Market is Forecast to Increase at a CAGR of 2.8% Until 2017
GBI Research estimates that the overall critical care market was worth $1,130.7m in 2010, representing a Compound Annual Growth Rate (CAGR) of 5% between 2002 and 2010. The global critical care market is expected to grow at a moderate rate of 2.8% between 2010 and 2017, and is anticipated to reach $1,372.4m in 2017. The increased availability and usage of PCC, albumin products and factor concentrates for the management of various bleeding complications, and high risk surgical settings such as trauma, PPH (post partum hemorrhages), cardiac surgery and liver diseases, will drive the market in future. Approvals and launches of new products such as Riastap, Corifact and Atryn, and the anticipated launch of recombinant products, will boost growth in the critical care market in the forecast period.
Critical care market, Global Revenue ($m), 2002-2017
Source: GBI Research, FDA, EMEA, PMDA, JAPIC, ZenRx, Company Annual Reports and Websites, ClinicalTrials.gov
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
